# Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study

> **NCT02262702** · — · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Paracetamol 665 mg
- **DRUG:** Paracetamol 500 mg

## Key facts

- **NCT ID:** NCT02262702
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262702, "Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02262702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*